AuntMinnie.com staff writersMRIGE HealthCare secures FDA clearances for Signa MRI techGE HealthCareGE HealthCare has received U.S. FDA clearance for three MRI technologies in the company's Signa suite.February 19, 2026Nuclear MedicineStarget and CMIT collaborateThe strategic collaboration aims to develop peptide radioligand therapies for cancer.February 18, 2026Nuclear MedicineNorthStar inks Ac-225 supply deal with BioemtechInitial deliveries will begin in the first quarter of 2026.February 18, 2026CTUniversity of South Florida installs GEHC image-guided therapy systemThe university will integrate Allia Moveo into its education and simulation programs for multidisciplinary teams.February 17, 2026UltrasoundGEHC expands on AI-powered ultrasound BARDA contractGEHC will build on its collaboration with BARDA in developing AI-powered ultrasound tools for mass-casualty events.February 17, 2026AICercare Medical releases suite update for neuroimagingCercare Medical has released version 18 of its Cercare Medical Neurosuite including updates for both stroke and oncology workflows.February 17, 2026Radiation Oncology/TherapyUNC Health to install Mevion’s proton therapy systemUNC Health will install Mevion's S250-FIT after converting a treatment room to support proton therapy in its established oncology ecosystem.February 17, 2026PACS/VNAPa.-based St. Luke's implements Sectra enterprise imagingSectraThe platform allows all images to flow into one storage environment and for studies to be retrieved across the network, St. Luke's says.February 13, 2026Image-Guided SurgeryOncoRes secures $19M on path to U.S. trialThe funds will support clinical development and regulatory milestones for OncoRes' quantitative micro‑elastography imaging system.February 13, 2026Molecular ImagingStanford pulls in Atley and Telix for At-211 supply in western U.S.The project is funded by VINNOVA through a 2025 collaboration with the U.S., U.K., and Singapore.February 13, 2026Page 1 of 235Next PageTop StoriesRadiation Oncology/TherapyRadiopharmaceutical therapy use increased 20-fold over a decadeIntravenous administrations of cancer therapies such as Xofigo, Lutathera, and Pluvicto have increased by more than 2000%.CTUsing GPT‑4o with CT exams helps diagnose ovarian cancer earlierWomens ImagingSurvey: Nearly 4 out of 5 practices short on breast imagersRadiation Oncology/TherapyPooled evidence: Lu-177 PSMA-617 vs. established therapies in mCRPCSponsor ContentHow Agentic AI Is Transforming Radiology Ops